resulted in increased nuclear CD9 fluorescence. CD9 was also found, along with a plasma membrane-associated pool, in the nuclei of all primary ductal breast carcinoma patient specimens analyzed. In all patients, about 40% of the total CD9 cellular fluorescence was nuclear. CD9 co-localized at the nuclear level with CEP97, a protein implicated in centrosome function, and with the IGSF8, an established CD9 partner in the plasma membrane.
Ͷ check every two weeks. Complete culture medium consisted of RPΜΙ−1640 medium (Gibco, Carlsbad, CA), 10% fetal bovine serum (Atlanta Biologicals, Inc., Norcross, GA), 100 units/ml penicillin, 100 μg/ml streptomycin, and 2 mM L-glutamine. Western blotting. Cells were lysed with 50 mM Tris-HCl, pH 7.5 + 100 mM NaCl + 1% Triton X-100, and incubated on ice for 30 minutes. The lysates were centrifuged at 200 x g for 5 minutes to remove unlysed cells and nucleic acids, then the supernatants were loaded onto a 4-12% Bis-Tris precast gel (Invitrogen, Grand Island, NY), along with a pre-stained protein molecular weight ladder (Genetex, Irvine, CA). The gel was transferred to a nitrocellulose membrane, and afterwards incubated in a blocking buffer consisting of PBS + 1% BSA overnight at 4 o C. The membrane was probed with a primary Ab overnight at 4 o C. The membrane was washed 3 times for 10 minutes each using PBS + 0.1% Tween 20, and afterwards incubated with a secondary Ab (Licor, Lincoln, NE) for 30 minutes at room temperature (RT). The membrane was washed again 3 times for 10 minutes each in PBS + 0.1% Tween 20 , then rinsed in ddH 2 O prior to viewing by an Odyssey CLx system (Licor). Author Manuscript Published OnlineFirst on August 7, 2014; DOI: 10.1158 /1541 ͷ a scrambled sequence that will not lead to the specific degradation of any known cellular mRNA, were employed as control. For transduction, retroviral supernatants or transduction-ready lentiviral particles were preloaded onto recombinant fibronectin (Retronectin, Takara Shuzo, Japan)-coated plates and centrifuged at 950 x g for 30 min at 4 o C. The operation was repeated a second time with fresh supernatant. The supernatant was then removed and the plates washed with PBS before addition of cells. After transduction, stable cell lines were isolated via selection with 2 μg/ml puromycin. A few days later, cells were cloned by limiting dilution.
Antibodies

Retroviral and Lentiviral
Transfection of CD9-GFP plasmid. MDA, MA-11 and MCF-7 cells were electroporated with 10 μg of CD9 cDNA PS100010 plasmid (ORF with C-terminal GFP tag) (OriGene Tech., Rockville, MD), employing a Gene Pulser X-cell electroporator (Bio-Rad, Hercules, CA). CD9-GFP-positive cells were selected by 400 μg/ml G-418. G-418 was removed from the medium at least one week before the experiments. Author Manuscript Published OnlineFirst on August 7, 2014; DOI: 10.1158 /1541 microscope. GFP donor and TRITC acceptor channels were collected using 500-550 nm, and 570-620 longpass filters, respectively. Z-stacks were acquired prior to FRET imaging for co-localization analysis. The Coloc 2 plugin of Fiji was used to determine Pearson's coefficients of ROIs within background-subtracted images. A two-tailed Student's t-test assuming equal variance was used to compare Pearson's coefficients between samples. Values are reported as averages +/-SEM. FRET was performed using the acceptor photo-bleaching method (15). Donor and acceptor channels were recorded every 11s for 576s total. Between image acquisition points, the acceptor was bleached for 8s within specific ROIs using the 561 nm laser at 80% power and 12.1 pixel dwell settings.
Confocal
Immunoprecipitation. Nuclear and cytoplasmic fractions of MDA-CD9-GFP and MA-11-CD9-GFP cells, with and without anti-CD9 mAb treatment, were isolated using NE-PER nuclear and cytoplasmic extraction reagents (ThermoScientific, Grand Island, NY) in the presence of 1X halt protease inhibitor cocktail (ThermoScientific) to prevent protein degradation. Isolated cytoplasmic and nuclear fractions were added to 20 μl pre-equilibrated GFP-Trap magnetic particles bound to a GFP-binding protein (16) (Chromotek, PlaneggMartinsried, Germany), incubated overnight at 4 o C with constant rotation, and subsequently eluted with TruSep SDS sample buffer (NuSep, Bogart, GA) supplemented with 5% ȕ-ME.
Immunohistochemistry. 4 ȝm-breast cancer tissue slices from five patients with ductal carcinoma of the breast were de-paraffinized and rehydrated. Antigen retrieval was performed using 10 mM sodium citrate, pH 6.0, ͺ (Electron Microscopy Sciences) was added to slides, which were then mounted with coverslips and viewed using a 60X oil-immersion Apo-TIRF objective (NA 1.39) on an A1R+ confocal microscope.
RESULTS
Nuclear localization of CD9 in BCC.
We investigated by confocal laser microscopy the cellular localization of CD9 in fixed and permeabilized MDA, MA-11 and MCF-7 cells. In all three BCC lines, in addition to the main plasma membrane/cytoplasmic pool, a nuclear pool of CD9 was observed (Fig. 1) . Exposure of MDA to anti-CD9 mAb (clone H19a, Biolegend) for 90 min at 37 o C resulted in a 2-fold increase in nuclear CD9 fluorescence (Figs. 2a, 3b) . No increase was observed for MA-11 and MCF-7 cells (Fig. 2a) . The results were confirmed by using the P1/33/2 anti-CD9 mAb (Santa Cruz), targeted at a different epitope (not shown). To confirm the presence of a nuclear CD9 pool, we stably transfected MDA, MA-11 and MCF-7 cells with a CD9-GFP fusion plasmid. As for endogenous CD9, CD9-GFP was detected in the nuclei of MDA (Fig. 3) , MA-11 and MCF-7 cells (Suppl. Fig. 1 ), along with a plasma membrane/cytoplasmic pool. Exposure of MDA/CD9-GFP to anti-CD9 mAb for 90 min at 37 o C resulted in a 2.8-fold increase in nuclear levels of CD9-GFP (Fig. 3) . CD9 was not detectable in nuclei of HuMEC under baseline conditions, with minimal positivity upon exposure to anti-CD9 mAb (Suppl. Fig. 2) . A phycoerythrin-conjugated secondary Ab alone, or a monoclonal antibody directed against an external epitope of CD44, as negative controls, did not show nuclear positivity in any of the three BCC lines (Suppl. Fig. 3 ). To pinpoint the nuclear localization of CD9, we calculated for each experimental condition the mean fluorescence of CD9 or DAPI within the nuclear region for each Z-slice for at least 3 XY positions. The means were then divided by the maximum mean value for each Z-stack, plotted against Z-slice number and the curves baseline corrected ( (Fig, 2b, arrow) . This could be due to the over-expression of CD9 in MDA-CD9-GFP Presence of CD9 in BCC nuclei was confirmed by immune-reactivity of CD9-GFP in nuclear extracts from MDA-CD9-GFP and MA-11-CD9-GFP cells (Fig. 4a) . Also, incubation with anti-CD9 Ab for 90 min resulted in an increase in nuclear levels of CD9 in MDA and MA-11 cells. The purity of the nuclear fraction was established by the almost exclusive association of ADAM10 with the cytoplasmic fraction of both MDA and MA-11 cells; interestingly, in both MDA and MA-11 cells, Cep-97 was mainly associated with the nuclear fraction ( Fig. 4a ). To confirm the nuclear association of CD9 with Cep97 and IgSF8, we analyzed by confocal microscopy MDA-CD9-GFP cells stained with PE-conjugated secondary Ab bound to anti-Cep97 and anti-IgSF8 monoclonal Abs.
CD9 associates with
For both proteins, a punctate pattern of distribution was observed, Cep97 being mainly localized to the nucleus (Fig. 4c) , and IgSF8 to membrane and cytoplasm (Fig. 4e) . Upon pre-incubation with CD9 mAb, both antigens were localized mainly in the nucleus, and co-localized with CD9 (Fig. 4d, f ͳͲ CD9 and Cep97 and CD9 and IgSF8 was direct, we performed FRET analysis using the acceptor photobleach method (Fig. 5) . MDA-CD9-GFP cells were stained with anti-Cep97 or anti-IgSF8 antibodies, followed by a TRITC-conjugated secondary antibody. The acceptor (TRITC) was sequentially bleached, followed by donor (GFP) and acceptor acquisition for 576s total. Relative fluorescence values for GFP and TRITC over time are shown in Figure 5 c-d. As TRITC fluorescence decreased over time, there was no observable increase in donor fluorescence in either Cep97-or IgSF8-stained dishes. This indicates no direct association (within 10 nm) between Cep97 and CD9 nor IgSF8 and CD9.
CD9 knockdown induces multipolar mitoses and poly-nucleation. To investigate whether binding of CD9 to
Cep97 affected centrosome function, we knocked down CD9 in MDA and MCF-7 cells by a pool of three specific shRNAs. Complete depletion of CD9 was evidenced by complete lack of mAb reactivity (Suppl. Fig.   4 ). A large increase in multipolar mitoses, potential cause of heterogeneity and aneuploidy, was observed in CD9-knockdown BCC vs. their mock-transduced counterparts (Fig. 6a-b) . Thus, while 2.8% and none of mitotic figures observed in parental MDA and MCF-7, respectively, were multipolar, the percentage increased to 15% and 4.6% for CD9-knockdown cell lines (Fig. 6d) . No multipolar mitoses were observed in MSC. Also, higher numbers of poly-nucleated cells were observed in BCC after CD9 knockdown (Fig. 6c, e) . We then investigated whether the addition of anti-CD9 antibodies increased CD9-dependent nuclear-related functions.
Exposure of MDA cells to 25 μg/ml anti-CD9 mAb at 37 o C resulted in a 4.2 + 0.5-fold and a 2.1 + 0.3-fold increase in poly-nucleated cells and atypical mitoses, respectively (Fig. 6d, e) .
Nuclear localization of CD9 in primary tumors of breast carcinoma patients. To establish the clinical relevance of our observations, we then investigated by confocal laser microscopy the intracellular localization of CD9 in formalin-fixed paraffin-embedded sections from primary ductal carcinomas of the breast (Suppl. Table 1 ). In all cases, in addition to plasma membrane-associated positivity, a nuclear pool of CD9 was observed with MEM-61 (Abcam) (Fig. 7) and 72F6 (Thermo) mAbs (Suppl. Fig. 5 ), directed against different CD9 epitopes. In agreement with previous findings (18), CD9 staining at the plasma membrane/cytoplasm level was usually homogeneous, with all cells showing a similar intensity. Also nuclear positivity was homogeneous among patients, as assessed by the ratio of nuclear over total fluorescence (NF/TF) (Suppl. 
DISCUSSION
We have herein identified by confocal microscopy and immunoblotting a nuclear pool of the tetraspanin CD9 in MDA, MA-11, and MCF-7 cells under naïve conditions and upon forced expression of a CD9-GFP fusion protein. Nuclear CD9 was also found in tumor sections from patients with ductal breast carcinoma. To the best of our knowledge, this is the first non-anecdotal report of a nuclear pool of a tetraspanin protein. Nuclear CD9 staining was previously described for WM9 melanoma cells, but its possible implications were not discussed in that study (19) .
We found by confocal microscopy and co-IP that CD9 co-localizes with IgSF8 and Cep-97 at the nuclear level.
Since both CD9 and IgSF8 are considered non-nuclear proteins, their nuclear association was surprising.
However, the two proteins reportedly (6) have a stoichiometric interaction, suggesting that in MDA they might translocate as a complex from plasma membrane and membrane protrusions to the nucleus. The structural similarity between IgFS8 and anti-CD9 monoclonal Ab, belonging to the same Ig superfamily, suggests that, as observed for anti-CD9, binding of IgFS8 to CD9 triggers the translocation of the CD9-IgFS8 complex to the nucleus, where it binds Cep97, regulating the mitotic process. However, since FRET experiments showed no direct binding of CD9 to Cep-97 or IgSF8, it is conceivable that CD9 translocates to the nucleus as a larger protein complex. Both CD9 knock-down and addition of anti-CD9 monoclonal Ab to parental cells resulted in multipolar mitoses and poly-nucleation, suggesting that CD9 is involved in centrosomal function. This is supported by the following observations: (i) Cep97 was present mainly in BCC nuclei by both Western blotting and confocal laser microscopy; (ii) Cep97 is known to be required for the recruitment of CP110, a protein that regulates centrosomal duplication (17); (iii) in BCC, CD9 knock-down resulted in multipolar mitoses and polyploidy, phenocopying the effects described by others in BCC upon Cep97 or CP110 knockdown (17) 2014; DOI: 10.1158 /1541 ͳʹ multipolar spindles and poly-nucleation. However, cell fusion is not the cause of the mitotic abnormalities observed upon abrogation of CD9 expression, because in CD9-knockdown MDA cells and in the presence of CD9 blocking antibodies both processes of cell invasion and fusion are decreased (Rappa et al., manuscript in preparation).
The prognostic value of CD9 expression is currently unclear; while some studies found an association between decreased CD9 expression and poor prognosis (24-26), others found no significant correlation (18, 27) . Our discovery of a nuclear CD9 pool associated with Cep97, together with our finding that CD9 is a determinant of invasiveness and cell fusion (Rappa et al., manuscript in preparation), shed some light on the "push and pull" role of tetraspanins in metastases (3): loss of CD9 expression might predispose to tumor development through the formation of heterogeneous aneuploid clones induced by mitotic abnormalities, while re-expression of CD9 might subsequently favor invasiveness, heterologous fusion, and the development of metastasis. Consistent with this hypothesis, while melanoma cells reportedly (19) had reduced CD9 expression relative to normal melanocytes, forced increase in CD9 expression stimulated their invasiveness. Similarly, in cervical cancers, CD9 was down-regulated in primary sites, but re-expressed at sites of trans-endothelial invasion to promote the expansion of malignant cells (28). Our findings warrant further studies to (i) evaluate in large cohorts of patients with ductal breast carcinoma whether nuclear CD9 has prognostic value or can predict therapeutic response and (ii) develop novel CD9-targeted therapeutics to specifically interfere with the function of nuclear CD9 in BCC. Author Manuscript Published OnlineFirst on August 7, 2014; DOI: 10.1158 /1541 ʹͲ nucleated cells for mock-transfected MDA and MCF-7 cells compared with cells transfected with CD9shRNA plasmid, selected for one week with 400 μg/ml G-418, and grown for one more week in the absence of G-418.
Columns, means of 3 experiments; bars, SD. *, p<0.05; **, p<0.01. Statistical significance was determined using a two-tailed Student's t-test, and p-values < 0.05 were considered significant by ANOVA. Figure 7 . Nuclear expression of CD9 in breast cancer patients. Upon de-paraffination, re-hydration and antigen retrieval, 4 ȝm-breast cancer tissue slices from five patients with ductal carcinoma of the breast were incubated with anti-CD9 Ab (Abcam) and anti-pan-cytokeratin Ab (Santa Cruz Biotech), followed by Cy5-conjugated anti-mouse and FITC-conjugated anti-rabbit secondary antibodies, and then stained with DAPI.
Images are horizontal maximum intensity projections of z-stacks. Scale bars represent 50 ȝm for images on left, 10 ȝm for images on the right. Green, pan-cytokeratin; red, CD9; blue, DAPI. 
